The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are ...

Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

Johnson & Johnson JNJ announced that the FDA has granted approval to its key drug, Tremfya, for its second inflammatory bowel ...

Dermatologists are increasingly prescribing minoxidil in low-dose pills to help men and women regrow hair. The practice ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling ...

Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...

(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH in clinical trials to help identify the severity of a type of ...

The stringent action is meant to prevent criticism of quality of drugs produced in the country and to prevent any non-tariff ...

US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with ...

US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays for ...